NFGH
LAB icon

Nan Fung Group Holdings’s Standard BioTools LAB Stock Holding History

Nan Fung Group Holdings’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,883,179
Closed -$2.41M – 26
2025
Q4 		$2.41M Hold
1,883,179
– – 2.16% 14
2025
Q3 		$2.45M Hold
1,883,179
– – 4.11% 10
2025
Q2 		$2.26M Hold
1,883,179
– – 3.56% 10
2025
Q1 		$2.03M Hold
1,883,179
– – 1.66% 21
2024
Q4 		$3.3M Hold
1,883,179
– – 2.82% 17
2024
Q3 		$3.63M Hold
1,883,179
– – 3.13% 14
2024
Q2 		$3.33M Hold
1,883,179
– – 3.56% 11
2024
Q1 		$5.1M Buy
+1,883,179
New +$4.55M 4.73% 5

Other funds holding LAB

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
MCO
MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HBWM
Hollow Brook Wealth Management Katonah, New York $392M AUM 36.68% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Nan Fung Group Holdings's LAB Position: Q1 2026 in Review

Nan Fung Group Holdings sold out of Standard BioTools (LAB) in Q1 2026, closing a stake of 1,883,179 shares — an estimated $2.41M sold.

Nan Fung Group Holdings first reported a position in LAB in Q1 2024 and held it in 8 quarters. The position peaked at $5.1M in Q1 2024. 155 funds tracked by Wall St. Rank hold LAB as of Q1 2026.

  • Nan Fung Group Holdings reported no remaining Standard BioTools position as of Q1 2026 after selling out during the quarter.
  • Nan Fung Group Holdings sold 1,883,179 Standard BioTools shares in Q1 2026, an estimated $2.41M.
  • Nan Fung Group Holdings first reported a position in Standard BioTools in Q1 2024 and held it in 8 quarters.
  • Nan Fung Group Holdings's Standard BioTools position peaked at $5.1M in Q1 2024.
  • 155 funds tracked by Wall St. Rank held Standard BioTools as of Q1 2026.

Based on Nan Fung Group Holdings's 13F filing for Q1 2026, filed 14 May 2026.